Commentary on pravastatin and cancer: need for individual patient data meta-analyses

Pharmacoepidemiol Drug Saf. 2010 Feb;19(2):203-4; author reply 205. doi: 10.1002/pds.1910.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Anticholesteremic Agents / adverse effects
  • Anticholesteremic Agents / pharmacology*
  • Controlled Clinical Trials as Topic
  • Humans
  • Japan
  • Meta-Analysis as Topic*
  • Middle Aged
  • Neoplasms / complications*
  • Pravastatin / adverse effects
  • Pravastatin / pharmacology*
  • Reference Standards

Substances

  • Anticholesteremic Agents
  • Pravastatin